All had good response to dopaminergic therapy, abnormal dopamine transporter single‐photon emission computed tomography striatal uptake and a disease course consistent with PD, without clear atypical features, behavioral, or cognitive deficits. Here, SLC6A3 is linked to Parkinson disease.